Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli

Science

Volumn 282, Issue 5393, 1998, Pages 1494-1497

  Mulvey, Matthew A ^a   Lopez Boado, Yolanda S ^a   Wilson, Carole L ^a   Roth, Robyn ^a   Parks, William C ^a   Heuser, John ^a   Hultgren, Scott J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; MEMBRANE PROTEIN; PROTEIN SERINE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIUM PILUS; BLADDER; ENZYME ACTIVATION; EPITHELIUM CELL; ESCHERICHIA COLI; HOST CELL; HOST RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; URINARY TRACT INFECTION; UROTHELIUM;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0032553579     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.282.5393.1494     Document Type: Article

References (44)

1. T. M. Hooton and W. E. Stamm, Infect. Dis. Clin. N. Am. 11, 551 (1997).
2. S. Langermann et al., Science 276, 607 (1997).
3. C. H. Jones et al., Proc. Natl. Acad. Sci. U.S.A. 92, 2081 (1995).
4. H. Connell et al., ibid. 93, 9827 (1996); K. Thankavel et al., J. Clin. Invest. 100, 1123 (1997).
5. H. Connell et al., ibid. 93, 9827 (1996); K. Thankavel et al., J. Clin. Invest. 100, 1123 (1997).
6. K. Ishikawa et al., in preparation.
7. R. M. Hicks, Biol. Rev. 50, 215 (1975); T.-T. Sun et al., Mol. Biol. Rep. 23, 3 (1996).
8. R. M. Hicks, Biol. Rev. 50, 215 (1975); T.-T. Sun et al., Mol. Biol. Rep. 23, 3 (1996).
9. X.-R. Wu, T.-T. Sun, J. J. Medina, Proc. Natl. Acad. Sci. U.S.A. 93, 9630 (1996).
10. 8 colony-forming units) in phosphate-buffered saline (PBS) (2). Mice were killed, and their bladders were aseptically removed at the indicated time points.
11. NU14 type 1 pili were purified and characterized biochemically, genetically [S. J. Hultgren, J. L. Duncan, A. J. Schaeffer, S. K. Amundsen, Mol. Microbiol. 4, 1311 (1990)], by immunogold EM, and by high-resolution EM.
12. 2, coated with ∼150 Å of gold, and examined with a Hitachi S-4500 FEG Scanning Electron Microscope. Two or more bladders were examined for each type of sample.
13. M. A. Mulvey and S. J. Hultgren, unpublished data.
14. For high-resolution EM, fixed bladder samples were freeze-fractured, deep-etched, and rotary-replicated [J. E. Heuser, J. Muscle Res. Cell Motil. 8, 303 (1987)]. Similar images of bacterial attachment through shortened pili were obtained whether bladders were infected in vivo for 2 hours or ex vivo (after removal from the mice) for 30 min.
15. C. C. Brinton Jr., Trans. N.Y. Acad. Sci. 27, 1003 (1965).
16. C. P. Novotny and P. Fives-Taylor, J. Bacteriol. 117, 1306 (1974); C. Langenaur and N. Agabian, ibid. 131, 340 (1977); M. Romantschuk and D. H. Bamford, J. Gen. Virol. 66, 2461 (1985); D. E. Bradley, J. Gen. Microbiol. 72, 303 (1972).
17. C. P. Novotny and P. Fives-Taylor, J. Bacteriol. 117, 1306 (1974); C. Langenaur and N. Agabian, ibid. 131, 340 (1977); M. Romantschuk and D. H. Bamford, J. Gen. Virol. 66, 2461 (1985); D. E. Bradley, J. Gen. Microbiol. 72, 303 (1972).
18. C. P. Novotny and P. Fives-Taylor, J. Bacteriol. 117, 1306 (1974); C. Langenaur and N. Agabian, ibid. 131, 340 (1977); M. Romantschuk and D. H. Bamford, J. Gen. Virol. 66, 2461 (1985); D. E. Bradley, J. Gen. Microbiol. 72, 303 (1972).
19. C. P. Novotny and P. Fives-Taylor, J. Bacteriol. 117, 1306 (1974); C. Langenaur and N. Agabian, ibid. 131, 340 (1977); M. Romantschuk and D. H. Bamford, J. Gen. Virol. 66, 2461 (1985); D. E. Bradley, J. Gen. Microbiol. 72, 303 (1972).
20. D. G. Thanassi et al., Proc. Natl. Acad. Sci. U.S.A. 95, 3146 (1998).
21. C. H. Jones et al., EMBO J. 16, 6394 (1997).
22. T. Walz et al., J. Mol. Biol. 248, 887 (1995); X.-R. Wu, J. J. Medina, T.-T. Sun, J. Biol. Chem. 270, 29752 (1995).
23. T. Walz et al., J. Mol. Biol. 248, 887 (1995); X.-R. Wu, J. J. Medina, T.-T. Sun, J. Biol. Chem. 270, 29752 (1995).
24. Y. Fukushi, S. Orikasa, M. Kagayama, Invest. Urol. 17, 61 (1979); L. A. McTaggart, R. C. Rigby, T. S. J. Elliott, J. Med. Microbiol. 32, 135 (1990).
25. Y. Fukushi, S. Orikasa, M. Kagayama, Invest. Urol. 17, 61 (1979); L. A. McTaggart, R. C. Rigby, T. S. J. Elliott, J. Med. Microbiol. 32, 135 (1990).
26. C. P. Davis, D. T. Uehling, K. Mizutani, E. Balish, in Scanning Electron Microscopy, R. P. Becker and O. Johari, Eds. (AMF, O'Hare, IL, 1978), vol. II, pp. 315-320; S. Orikasa and J. F. Hinman, Invest. Urol. 15, 185 (1977); T. S. J. Elliott, L. Reed, R. C. B. Slack, M. C. Bishop, J. Infect. 11, 191 (1985).
27. C. P. Davis, D. T. Uehling, K. Mizutani, E. Balish, in Scanning Electron Microscopy, R. P. Becker and O. Johari, Eds. (AMF, O'Hare, IL, 1978), vol. II, pp. 315-320; S. Orikasa and J. F. Hinman, Invest. Urol. 15, 185 (1977); T. S. J. Elliott, L. Reed, R. C. B. Slack, M. C. Bishop, J. Infect. 11, 191 (1985).
28. C. P. Davis, D. T. Uehling, K. Mizutani, E. Balish, in Scanning Electron Microscopy, R. P. Becker and O. Johari, Eds. (AMF, O'Hare, IL, 1978), vol. II, pp. 315-320; S. Orikasa and J. F. Hinman, Invest. Urol. 15, 185 (1977); T. S. J. Elliott, L. Reed, R. C. B. Slack, M. C. Bishop, J. Infect. 11, 191 (1985).
29. Y. C. Wong and B. F. Martin, Am. J. Anat. 150, 237 (1977).
30. -), and pDC1 (P pilus gene cluster) have been described [P. E. Orndorff and S. Falkow, J. Bacteriol. 159, 736 (1984); F. C. Minion, S. N. Abraham, E. H. Beachey, J. D. Goguen, ibid. 165, 1033 (1989); S. Clegg, Infect. Immun. 38, 739 (1982)].
31. -), and pDC1 (P pilus gene cluster) have been described [P. E. Orndorff and S. Falkow, J. Bacteriol. 159, 736 (1984); F. C. Minion, S. N. Abraham, E. H. Beachey, J. D. Goguen, ibid. 165, 1033 (1989); S. Clegg, Infect. Immun. 38, 739 (1982)].
32. -), and pDC1 (P pilus gene cluster) have been described [P. E. Orndorff and S. Falkow, J. Bacteriol. 159, 736 (1984); F. C. Minion, S. N. Abraham, E. H. Beachey, J. D. Goguen, ibid. 165, 1033 (1989); S. Clegg, Infect. Immun. 38, 739 (1982)].
33. -), and pDC1 (P pilus gene cluster) have been described [P. E. Orndorff and S. Falkow, J. Bacteriol. 159, 736 (1984); F. C. Minion, S. N. Abraham, E. H. Beachey, J. D. Goguen, ibid. 165, 1033 (1989); S. Clegg, Infect. Immun. 38, 739 (1982)].
34. R. Mittler and E. Lam, Trends Microbiol. 4, 10 (1996); C. B. Thompson, Science 267, 1456 (1995); A. Zychlinsky and P. Sansonetti, J. Clin. Invest. 100, 493 (1997).
35. R. Mittler and E. Lam, Trends Microbiol. 4, 10 (1996); C. B. Thompson, Science 267, 1456 (1995); A. Zychlinsky and P. Sansonetti, J. Clin. Invest. 100, 493 (1997).
36. R. Mittler and E. Lam, Trends Microbiol. 4, 10 (1996); C. B. Thompson, Science 267, 1456 (1995); A. Zychlinsky and P. Sansonetti, J. Clin. Invest. 100, 493 (1997).
37. M. Barinaga, Science 280, 32 (1998); G. M. Cohen, Biochem. J. 326, 1 (1997).
38. M. Barinaga, Science 280, 32 (1998); G. M. Cohen, Biochem. J. 326, 1 (1997).
39. Mice were inoculated transurethrally with 50 μl of a 400 μM solution of BAF (Enzyme Systems Products) [M. Deshmukh et al., J. Cell Biol. 135, 1341 (1996)] in PBS 1 hour before inoculation with NU14 containing an additional dose of the drug. Control mice were inoculated with dimethyl sulfoxide in place of BAF. Bladders were recovered at 6 or 24 hours after infection for SEM (10). NU14 titers from bladders were determined at 12 hours after infection (2). BAF had no effect on the viability or growth rate of NU14 in control in vitro experiments.
40. 4, 10 mM glucose, and 5 mM Hepes (pH 7.4)] and gently rinsed. One-half of each bladder was incubated with, and one half without, Ringer solution supplemented with gentamicin (100 μg/ml) for 90 min at room temperature. This incubation with gentamicin was sufficient to kill any external bacteria. Bladder halves were washed with PBS, weighed, and homogenized in 1 ml of 0.025% Triton X-100/PBS, and surviving bacteria were plated (2).
41. A. Stapleton and W. E. Stamm, Infect. Dis. Clin. N. Am. 11, 719 (1997); R. Ikäheimo et al., Clin. Infect. Dis. 22, 91 (1996); B. Foxman et al., J. Infect. Dis. 172, 1536 (1995).
42. A. Stapleton and W. E. Stamm, Infect. Dis. Clin. N. Am. 11, 719 (1997); R. Ikäheimo et al., Clin. Infect. Dis. 22, 91 (1996); B. Foxman et al., J. Infect. Dis. 172, 1536 (1995).
43. A. Stapleton and W. E. Stamm, Infect. Dis. Clin. N. Am. 11, 719 (1997); R. Ikäheimo et al., Clin. Infect. Dis. 22, 91 (1996); B. Foxman et al., J. Infect. Dis. 172, 1536 (1995).
44. We thank M. Veith for his help with SEM and E. M. Johnson and M. Deshmukh for their helpful suggestions and reagents. This work was supported by NIH grants R01AI29549 and R01DK51406. M.A.M. was supported by a Lucille P. Markey Special Emphasis Pathway in Human Pathobiology postdoctoral fellowship and by NIH fellowship AI09787. All animal experiments were performed under accredited conditions after approval of protocols by the local Animal Studies Committee.